Age: 1.5
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR
Symptoms: Antisocial behaviour, Autism, Coma, Social avoidant behaviour, Speech disorder
Clinical narrative: Information has been received regarding a case in litigation. It was reported that an 18 month old male child, who on 2/15/00 was vaccinated with MMR, developed autism spectrum disorder and pervasive developmental disorder. Concomitant therapy included poliovirus vaccine inactivated, HIB conjugate vaccine, diphtheria toxoid (+) pertussis acellular vaccine (+) tetanus toxoid, and hepatitis B vaccine. It was reported that the male child was born a perfectly normal, healthy baby boy. Developmentally, neurologically, and socially, he achieved every developmental milestone anticipated of all normally developing children. By two months of age, the baby boy was meeting developmental milestones and was alert, cooing, responding to sounds, responding to others and beginning to recognize and interact with his parents. At the age of 18 months, the boy was withdrawn, unable to speak and was unresponsive to his environment. His injuries included the loss of language skills, motor skills and affect. The child could no longer maintain eye contact with those around him, could no longer point his finger to recognize items and could no longer interact with his mother and father and others in his social environment. It was reported that the child had received numerous injections containing toxic mercury in the form of thimerosal in at least 14 doses administered between 12/4/98 and 11/9/01. A summary of the child's vaccinations are as follows: On 12/4/98, the child was vaccinated with hepatitis B vaccine. On 12/29/98 at approximately two months of age, the child received three vaccine injections including poliovirus vaccine inactivated, HIB cojugate vaccine, and diphtheria toxoid (+) pertussis acellular vaccine (+)tetanus toxoid. On 2/26/99, at approximately four months of age, the child received three more vaccine injections including poliovirus vaccine inactivated, HIB conjugate vaccine, and diphtheria toxoid (+) pertussis acellular vaccine (+) tetanus toxoid and HIB conjugate vaccine. On 7/29/99, at approximately nine months of age, the child received vaccination with hepatitis B vaccine. On 2/15/00, at approximately sixteen months of age, the child received vaccination with MMR. On 5/12/00, at eighteen months of age, the child received two more vaccine injections, including poliovirus vaccine inactivated, and HIB conjugate vaccine. On 11/7/00, at two years of age, the child received influenza virus whole virion 3v vaccine inactivated and pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine. On 12/7/00, at twenty five months of age, the child received influenza virus whole virion 3v vaccine inactivated. On 6/25/01, the child was diagnosed as having an autism spectrum disorder/pervasive developmental disorders. On 11/9/01, at three years of age, the child was vaccinated again with his final influenza virus whole virion 3v vaccine inactivated. It was reported that thimerosal used in vaccines and the MMR individually and/or jointly combined caused the child's autism spectrum disorder. Upon internal review, the autism spectrum disorder and pervasive developmental disorder were felt to be other important medical events (OMIC). Additional information has been requested. Follow up on 05/24/04 states: "Therapy with hepatitis B virus vaccine has been changed to concomitant suspect therapy from concomitant therapy."